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Investigation performed at the Applied Kinesiology Laboratory, Program in Physical Therapy,
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Background: Charcot neuropathic osteoarthropathy associated foot deformity can result in joint instability, ulceration,
and even amputation. The purpose of the present studywas to follow patients with andwithout active Charcot osteoarthropathy
for as long as two years to examine the magnitude and timing of foot alignment changes.
Methods: We studied fifteen subjects with Charcot osteoarthropathy and nineteen subjects with diabetes mellitus and
peripheral neuropathy without Charcot osteoarthropathy for one year; eight of the subjects with osteoarthropathy and five
of the subjects with diabetes and peripheral neuropathy were followed for two years. Bilateral weight-bearing radiographs
of the foot were made at baseline for all subjects, with repeat radiographs being made at six months for the osteoarthropathy
group and at one and two years for both groups. Radiographic measurements included the Meary angle, cuboid height,
calcaneal pitch, and hindfoot-forefoot angle.
Results: The Meary angle, cuboid height, and calcaneal pitch worsened in feet with Charcot osteoarthropathy over one
year as compared with the contralateral, uninvolved feet and feet in patients with diabetes and peripheral neuropathy.
Cuboid height continued to worsen over the two-year follow-up in the feet with Charcot osteoarthropathy. These feet also
had a greater change in the hindfoot-forefoot angle at one year as compared with the feet in patients with diabetes and
peripheral neuropathy and at two years as compared with the contralateral, uninvolved feet.
Conclusions: In patients with Charcot neuropathic osteoarthropathy, radiographic alignment measurements demon-
strate the presence of foot deformity at the time of the initial clinical presentation and evidence of progressive changes
over the first and second years. The six-month data suggest worsening of medial column alignment prior to lateral column
worsening. This radiographic evidence of worsening foot alignment over time supports the need for aggressive inter-
vention (conservative bracing or surgical fixation) to attempt to prevent limb-threatening complications.
Level of Evidence: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.
C
harcot neuropathic osteoarthropathy is characterized
by bone and joint destruction associated with periph-
eral neuropathy. Peripheral neuropathy can be the re-
sult of diabetes mellitus, chronic alcohol abuse, and heavy
metal exposure, or it can be idiopathic1,2. The onset of Charcot
arthropathy is commonly preceded by an undetected injury
that initiates an uncontrolled inflammatory process. This
unchecked peripheral hypervascular response is thought to
contribute to reduced bone mineral density in the foot3-5.
Continued weight-bearing on the injured and fragile foot can
result in fracture. Charcot arthropathy is associated with a high
frequency of fracture nonunion6, joint dislocation, foot de-
formity7-9, and skin ulceration10 and with an increased relative
risk of amputation by a factor as high as twelvefold2.
The Eichenholtz classification system is used to stage
Charcot arthropathy11-13. Stage 0, an addition by Shibata et al.14,
is the clinical phase in which the foot is warm, swollen, and red
with limited or no radiographic evidence of fracture. Stage I is
Disclosure: One or more of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in
support of an aspect of this work. In addition, one or more of the authors, or his or her institution, has had a financial relationship, in the thirty-six months
prior to submission of this work, with an entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written
in this work. No author has had any other relationships, or has engaged in any other activities, that could be perceived to influence or have the potential to
influence what is written in this work. The complete Disclosures of Potential Conflicts of Interest submitted by authors are always provided with the
online version of the article.
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the fragmentation or dislocation phase in which clinical signs
continue but fractures, joint dislocations, and deformity be-
come visible on radiographs. Stage II is the coalescence phase
with resorption or fusion of bone fragments. Stage III is the
consolidation phase, during which the foot becomes stable11-13,15.
The Schon anatomical location classification system is used
to identify deformity location7. There are four types: Type I
(Lisfranc pattern), Type II (naviculocuneiform pattern), Type
III (perinavicular pattern), and Type IV (transverse tarsal pat-
tern). The location, the magnitude of deformity, and the time
course are patient-specific, although it has been suggested that
it can take up to twenty-four months for the foot to become
stable16.
Treatment for Charcot arthropathy includes foot im-
mobilization and offloading until Eichenholtz stage III occurs.
Bracing or shoewear modifications are then required to ac-
commodate deformity, to prevent ulceration and deformity
progression, and to provide lower extremity stability for
weight-bearing activities1,2,17-20. While deformity progression is
a concern during stage II, the deformity is generally considered
stable at stage III and further alignment change is thought to
occur only with a recurrent episode of Charcot arthropathy.
However, the natural history of the magnitude and duration of
deformity progression has not previously been reported for this
disease. The purpose of the present study was to follow patients
with active Charcot arthropathy for as long as two years to
examine the magnitude and timing of foot alignment changes
in the sagittal and transverse planes.
Materials and Methods
Study Design Overview
Three groups of subjects were recruited for this study. The first group(designated as the CN group) included subjects who had active Charcot
arthropathy of any etiology. The second group (designated as the DMPN
group) included subjects with diabetes mellitus and peripheral neuropathy but
without a history of Charcot arthropathy; this group provided information
about alignment stability in patients at risk for the development of Charcot
arthropathy. The third group (designated as the unimpaired comparison group)
included subjects without diabetes mellitus, peripheral neuropathy, and Charcot
Fig. 1
Enrollment and follow-up of the study sample.
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arthropathy who had no known impairment. This group provided normative
data for baseline alignment measurements. Foot alignment measurements
were made on weight-bearing foot and ankle radiographs at baseline, six
months, one year, and two years for the CN group; at baseline, one year, and
two years for the DMPN group; and at baseline only for the unimpaired
comparison group. The two-year follow-up duration was chosen to permit
measurement of alignment changes in both the acute and chronic phases of
Charcot arthropathy
16,21
. All subjects provided written informed consent, in
compliance with the human studies protocol approved by the Human Re-
search Protection Office at Washington University School of Medicine. All
subjects were enrolled from June 2007 to August 2010 and received monetary
compensation for their time.
Inclusion/Exclusion Criteria
Subjects were considered for inclusion in the CN group if they met the fol-
lowing criteria: (1) peripheral neuropathy (the inability to feel a 5.07 Semmes-
Weinstein monofilament on at least one location on the plantar aspect of the
foot or the inability to feel <25 V with use of the biothesiometer), (2) clinical
signs of active Charcot arthropathy (redness, swelling, and elevated skin tem-
peratures), and (3) radiographic evidence of active Charcot arthropathy. Pa-
tients were excluded from the CN group if they had foot amputation proximal
to the phalanges or a history of osteomyelitis.
Subjects were included in the DMPN group if they met the following
criteria: (1) Type-1 or 2 diabetes mellitus, (2) peripheral neuropathy as defined
above, and (3) no medical history or radiographic evidence of active Charcot
arthropathy. Individuals were excluded if they had a history or current clinical
signs of foot disease, including plantar ulcerations, foot fractures, and/or fixed
midfoot or hindfoot deformities. In addition, individuals were excluded if they
were taking immunosuppressive medications or had a medical condition that
might impact foot bone health (e.g., foot or leg trauma, metabolic bone disease,
or a medical diagnosis of osteoporosis).
Subjects were included in the unimpaired comparison group if they met
the following criteria: (1) an age of less than forty-five years, (2) no known
medical condition at the time of enrollment, and, especially, (3) no medical
condition that might impact foot bone health.
Subject Characteristics
CN Group
Twenty subjects with active Charcot arthropathy met the study criteria and
agreed to participate, and fifteen of these subjects had complete data both at the
time of the first clinical presentation (baseline) and at one year (Fig. 1 and Ap-
pendix). The majority (ten) of the subjects in the CN group with one-year data
had peripheral neuropathy as a result of type-2 diabetes mellitus, whereas two
patients had type-1 diabetes mellitus. The remaining three patients had idio-
pathic peripheral neuropathy with hemoglobin A1c (HbA1c) values in the
prediabetic range (5.7% to 5.9%). Eight subjects in the CN group were able to
complete baseline, six-month, one-year, and two-year testing prior to the study
end date.
DMPN Group
Twenty subjects met the criteria for inclusion in the DMPN group, and nine-
teen had complete data at baseline and at one year. Five subjects in the DMPN
group had complete data at baseline, six months, one year, and two years prior
to the study end date.
Unimpaired Comparison Group
Sixteen subjects in the unimpaired comparison group completed baseline
testing. The involved foot was determined by means of a coin flip.
Radiographic Examination
Lateral, dorsoplantar, and oblique weight-bearing radiographs were made for
all subjects. A standardized protocol was followed with the feet prealigned by
the research coordinator and a radiopaque ruler included in each radiograph to
adjust for magnification error. Radiographs were made at baseline for all
subjects and were repeated at an average of six months (mean [and standard
deviation], 0.6 ± 0.2 years), one year (mean, 1.0 ± 0.3 years), and two years
(mean, 2.1 ± 0.2 years) for the CN group and at one year (mean, 1.1 ± 0.3 years)
and two years (mean, 2.0 ± 0.2 years) for the DMPN group. All radiographic
measurements were made by one rater (J.E.J.) as previously described
20
. Ra-
diographic measurements were made with use of the iSite PACS software
Fig. 2
Radiographs showing theMeary angle (a), cuboid height (b), calcaneal pitch (c), and transverse planemeasurements (d) at baseline (1), fifteenmonths (2),
and twenty-four months (3) for a representative patient with Charcot arthropathy. Note the progressive decline in the Meary angle, cuboid height, and
calcaneal pitch and the increase in forefoot abduction relative to the hindfoot over two years.
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(Philips Healthcare Informatics, Foster City, California), which provides length
measurements to the nearest 0.1 mm and angle measurements to the nearest 1.
Three measurements from the lateral radiograph provided an indication of
sagittal alignment. The Meary angle (measured in degrees) is the angle between
the line drawn from the center of the body of the talus bisecting the talar neck
and head and the line drawn through the longitudinal axis of the first meta-
tarsal. A negative angle represents arch lowering (Fig. 2). Cuboid height
(measured in millimeters) is the distance from the most plantar aspect of
the cuboid to a horizontal line drawn from the plantar calcaneal tuberosity to
the fifth metatarsal head. A smaller number represents arch lowering (Fig. 2).
Calcaneal pitch (measured in degrees) is the angle created by a line drawn from
the calcaneal tuberosity to the plantar aspect of the distal part of the calcaneus
and a horizontal line drawn from the plantar calcaneal tuberosity to the fifth
metatarsal head. A smaller angle indicates arch lowering (Fig. 2). Transverse
plane alignment was measured on the dorsoplantar radiograph with use of the
hindfoot-forefoot angle, which is the angle between the talocalcaneal bisector
and the second metatarsal shaft. A positive number represents adduction of the
forefoot on the hindfoot, and a negative number represents abduction of the
forefoot on the hindfoot (Fig. 2).
In our previous study, intra-rater precision was 3 for the Meary angle,
0.9 mm for cuboid height, and 2 for both calcaneal pitch and the hindfoot-
forefoot angle
20
. The least significant change, the smallest change considered
to be clinically real and not the result of chance for intra-rater measures
22
, was
9 for the Meary angle, 2.4 mm for cuboid height, 4 for calcaneal pitch, and
6 for the hindfoot-forefoot angle20.
Treatment of Charcot Neuropathic Osteoarthropathy
Medical treatment, including the choice of immobilization device and the
duration of immobilization, was determined by each individual’s care provider.
Immobilization consisted of total contact casting with transition to a removable
cast walker-boot for nine subjects
23
and a removable cast walker-boot only for
six subjects
24
(see Appendix). Nine patients received treatment from one of the
authors (D.R.S.), and the remaining six subjects received treatment from
providers not associated with the study (e.g., primary care physicians, com-
munity orthopaedists).
Statistical Methods
A group-by-side-by-time repeated-measures analysis of variance was per-
formed for the sagittal radiographic measures. A group-by-side analysis of
variance was performed for each baseline radiographic measure. Worsening of
alignment for the hindfoot-forefoot angle could be a change into greater ab-
duction or adduction, and therefore an absolute deviation score was calculated
over Years 1 and 2, and the results were compared with repeated-measures
contrasts. The baseline and one-year comparisons for each sagittal measure-
ment resulted in seventeen comparisons and a significant Bonferroni-corrected
Fig. 3
Figs. 3-A, 3-B, and 3-C Bar graphs showing the mean value (and standard error) at baseline, six months, one year, and two years for the Meary angle
(Fig. 3-A), cuboid height (Fig. 3-B), and calcaneal pitch (Fig. 3-C). Fig. 3-D Bar graph showing the mean change in the hindfoot-forefoot angle over Years
1 and 2.
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p value of £0.0029, which maintained the familywise error rate at an alpha of
<0.05. For the two-year comparisons, each sagittal radiographic measurement
resulted in thirty comparisons and a significant Bonferroni-corrected p value
of £0.0017. The hindfoot-forefoot comparison for Year 1 resulted in four
comparisons and a significant Bonferroni-corrected p value of £0.0125. For the
two-year comparisons of hindfoot-forefoot measurements, there were twenty-
four comparisons and a significant Bonferroni-corrected p value of £0.0021.
Results reported as p < 0.05 reflect these Bonferroni adjustments.
Source of Funding
This study was made possible by Grant Numbers R21 DK079457 and R01
DK059224 from the National Institute of Diabetes and Digestive and Kidney
Diseases, K12 HD055931 from the Eunice Kennedy Shriver National Institute
of Child Health and Human Development, and KL2 TR000450 from the
Institute of Clinical and Translational Sciences Multidisciplinary Clinical
Research Career Development Program, all of which are components of the
National Institutes of Health (NIH). Its contents are solely the responsibility
of the authors and do not necessarily represent the official view of NIH.
Results
CN Group Characteristics
In the CN group, thirteen subjects were classified as Eichenholtzstage I and two subjects were classified as stage II (see Ap-
pendix). According to the Schon anatomical location classifi-
cation system7, seven subjects had Lisfranc joint involvement
(Type I), four had transverse tarsal joint involvement (Type
IV), two had naviculocuneiform joint involvement (Type II),
one had perinavicular joint involvement (Type III), and one had
multiple joint involvement.
Alignment: Baseline and One Year
Change Over Time
Feet with Charcot arthropathy (the involved feet in the CN
group) had worsening alignment from baseline to one year in
all sagittal plane deformity measurements; the changes in cuboid
height and calcaneal pitch were significant (p < 0.05) (Fig. 3).
The mean change in the hindfoot-forefoot angle over one year
was greater in the involved feet in the CN group than in the feet
in the DMPN group (p < 0.05). There was no change in any
radiographic alignment measurement over one year in the un-
involved feet in the CN group or in the feet in the DMPN group.
Group and Foot Comparisons at Baseline and One Year
The involved feet in the CN group had worse mean sagittal
plane alignment than (1) the feet in the unimpaired compar-
ison group in terms of the Meary angle and cuboid height at
baseline (p < 0.05) and (2) the uninvolved feet in the CN group
and the feet in the DMPN group in terms of the Meary angle,
cuboid height, and calcaneal pitch at one year (p < 0.05).
Alignment: Baseline, Six Months, One Year, and Two Years
Change Over Time
The involved feet in the CN group worsened in terms of cuboid
height between baseline and two years (p < 0.05). In addition,
the change in the hindfoot-forefoot angle from baseline to two
years was greater in the involved feet in the CN group than in the
uninvolved feet in the CN group (p < 0.05). There were three
nonsignificant trends in the involved feet of the CN group: (1)
worsening of Meary angle occurred primarily during the first six
months, (2) worsening of cuboid height occurred between six
months and two years, and (3) progressive decrease in calcaneal
pitch occurred over the two-year follow-up period (Fig. 3).
Changes Greater Than the Least Significant Change
The least significant change (the smallest change considered to
be clinically real and not the result of chance) was calculated
from previous reliability work20. In the involved feet in the CN
group, alignment changes that exceeded the least significant
change were observed at one year in the Meary angle (six of
fifteen feet), cuboid height (seven of fifteen feet), calcaneal
pitch (seven of fifteen feet), and the hindfoot-forefoot angle
(five of fifteen feet). In this group, such changes were observed
at two years in the Meary angle (five of eight feet), cuboid
height (six of eight feet), calcaneal pitch (three of eight feet),
Fig. 4
Bar graphs showing the number of subjects (indicatedwithin the bar) with nomeasurements that changed (light pattern), one to twomeasures that changed
(mediumpattern), and three ormoremeasurements that changed (dark pattern) at one year (Fig. 4-A) and two years (Fig. 4-B). Note that no individual in the
control group had three or more measurements that changed over the two-year period.
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and the hindfoot-forefoot angle (seven of eight feet). Four or
fewer uninvolved feet in the CN group and three or fewer
uninvolved comparison feet in the DMPN group feet had
alignment changes greater than the least significant change at
one and two years (Table I).
Only the involved feet in the CN group had alignment
changes in three or more measurements in Year 1. One of these
individuals had alignment changes in three measurements in
the uninvolved foot during the two-year follow-up period and
was diagnosed with active Charcot arthropathy just prior to the
second-year follow-up visit. Most subjects in the DMPN group
had no change in any measurement greater than the least sig-
nificant change at both one year (seventeen of nineteen feet)
and two years (three of five feet) (Fig. 4).
Fracture Outcomes
Four subjects developed a fracture during the study period: two
subjects in the CN group had a new fracture in the involved
foot, one subject in the CN group developed stage-I Charcot
arthropathy in the uninvolved foot, and one subject in the
DMPN group developed a new foot fracture. All fractures were
associated with abnormalities in the Meary angle. Two fractures
occurred in subjects who had a poor Meary angle at baseline
(222 and 226), and two fractures occurred in subjects who
had a decrease of 11 in theMeary angle during the study period.
Although cuboid height was £10 mm at baseline in three of the
four subjects who had a new fracture, no other baseline align-
mentmeasurements or changes inmeasurements over timewere
consistently abnormal in the subjects with a new fracture.
Discussion
To our knowledge, the present study is the first to providelongitudinal radiographic alignment measures over one and
two years for individuals with active Charcot arthropathy. Sub-
jects with Charcot arthropathy had poor alignment at baseline,
with large alignment changes occurring during the first year,
despite cast and brace treatment, and evidence of smaller but
continued worsening of alignment during the second year.
Baseline to six-month data indicated large alignment changes
along themedial column of the foot (Meary angle), with changes
in alignment along the lateral column of the foot (cuboid height)
occurring during the second six months and the second year.
At the time of the initial clinical presentation, the involved
feet in the CN group had alignment measurements that were
worse than those of the uninvolved feet in the CN group, the feet
in the DMPN group, and the feet in the unimpaired comparison
group. Baseline measurements in the feet with Charcot arthrop-
athy were within the range reported by Schon et al.7 but were
worse than those recently reported by Hastings et al.20. Bevan and
Tomlinson10 reported a Meary angle that was similar to our
baseline measurement but a cuboid height that was worse and a
calcaneal pitch that was better. Differences inmeasured alignment
between studies could be the result of a number of factors. The
data in the present study were collected prospectively with use of
standardized weight-bearing radiographic methods. Previous
studies7,20 have been retrospective and have included non-weight-
bearing radiographic measures, which likely underestimate de-
formity severity. In addition, deformity severity at the time of the
initial clinical presentation may be related, in part, to the time
between the onset of Charcot arthropathy and study enrollment,
the aggressiveness of and compliance with immobilization treat-
ment, and whether the event being tracked during the study
period was a first event or a chronic recurrent event. The subjects
in the CN group had long, but typical, durations between event
onset and study enrollment. More than half of the subjects had
removable immobilization devices that allow noncompliance,
and four of the fifteen subjects had chronic recurrent Charcot
arthropathy with a history of diabetes-related foot complications.
TABLE I One and Two-Year Outcomes: Measurements That Changed Greater Than Least Significant Change
Measurement Change Greater Than Least Significant Change (no. of subjects)
Meary Angle Cuboid Height Calcaneal Pitch Hindfoot-Forefoot Angle
CN group
Involved
One year (n = 15) 6 7 7 5
Two years (n = 8) 5 6 3 7
Uninvolved
One year (n = 15) 1 2 0 4
Two years (n = 8) 1 1 1 2
DMPN group
Matched involved
One year (n = 15) 0 0 0 2
Two years (n = 8) 0 0 0 2
Matched uninvolved
One year (n = 15) 1 1 0 3
Two years (n = 8) 0 0 0 1
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The alignment of the involved feet in the CN group
worsened over one and two years, whereas the alignment re-
mained fairly stable in the uninvolved feet in the CN group and
the comparison feet in the DMPN group. The Meary angle in the
involved feet in the CN group changed most during the first six
months and remained stable through Year 2. A Meary angle of
lower than227 has previously been associated with the presence
of an ulcer10. In the present study, three subjects had progressive
worsening of the Meary angle below 227 during the first year,
with one developing an ulcer. In contrast, cuboid height changed
little during the first six months, with rapid changes occurring
during the second six months and the second year. Calcaneal
pitch showed a gradual and steady decline across all measurement
periods. Lateral column involvement in all patterns of foot de-
formity has been documented previously7 and is clinically asso-
ciated with a poor prognosis. The longitudinal data in the present
study suggest a progressive pattern of lateral column involvement
and highlight the need for early and aggressive treatment in an
effort to prevent progressive deformity over time across the foot.
The magnitude and timing of alignment change is vari-
able and is not readily predictable; however, our limited data
provide preliminary evidence that change in alignment greater
than measurement error is inevitable if sufficient follow-up
occurs. By the end of two years, all eight patients with Charcot
arthropathy had at least one alignment measure that exceeded
the least significant change. Future research must examine
factors that predict the magnitude and timing of alignment
change as well as treatment options to prevent what currently
results in inevitable deformity.
The present study had limitations that should be con-
sidered when interpreting the results. Most importantly, be-
cause of the small sample size, particularly for the two-year
follow-up, caution should be used when applying the results to
the patient population at large. Charcot arthropathy is variable
in its presentation and progression. The inclusion of multiple
etiologies of peripheral neuropathy as well as the lack of control
of intervention may have had an unpredictable impact on de-
formity progression in the present study. Although all patients
with Charcot arthropathy received an offloading treatment,
the type and duration was not controlled, and we do not know
the influence of the treatment variability on the course of the
condition. Studies with larger sample sizes are needed to more
fully assess the impact of group and patient-specific factors
(e.g., Charcot arthropathy location, severity, and treatment
type; etiology of peripheral neuropathy; comorbidities; and the
temporal relationship to the onset of the Charcot arthropathy)
on outcome. Another important limitation is that the two-year
follow-up is insufficient to fully assess the ultimate outcome of
Charcot arthropathy. Our study provides benchmark data to
guide larger, multicenter studies that can provide external
validity for our preliminary findings.
In conclusion, in patients with Charcot neuropathic os-
teoarthropathy, radiographic alignment measurements demon-
strated the presence of foot deformity at the time of the initial
clinical presentation. Longitudinal measures provided evidence
of progression of foot deformity over the first and second years.
Additionally, six-month interval data suggested that worsening
medial column alignment precedes worsening lateral column
alignment. The radiographic evidence of worsening foot align-
ment in a subset of patients with Charcot arthropathy indicates
the possible need for more aggressive orthopaedic intervention
to prevent limb-threatening complications resulting from severe
deformity.
Appendix
A table showing baseline subject characteristics is avail-
able with the online version of this article as a data sup-
plement at jbjs.org. n
Note: We would like to acknowledge Mary Wolfsberger and Joan Moulton for their assistance in
calibrating and loading radiographic images to iSite software.
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